Lori Frappier Selected Research

Latent Infection

12/2021	Epstein-Barr virus: Current questions and challenges.
3/2015	Regulation of herpesvirus reactivation by host microRNAs.
1/2015	EBNA1.
10/2014	Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer.
2/2014	Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.
1/2012	The Epstein-Barr Virus EBNA1 Protein.
12/2009	Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2).
11/2009	Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation.
12/2008	The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4.
10/2008	Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lori Frappier Research Topics

Disease

12	Infections 01/2022 - 06/2012
10	Latent Infection 12/2021 - 10/2008
9	Neoplasms (Cancer) 10/2021 - 02/2005
9	Leukemia 01/2018 - 11/2010
7	Epstein-Barr Virus Infections 01/2022 - 03/2002
7	Nasopharyngeal Carcinoma 10/2021 - 10/2008
5	Carcinoma (Carcinomatosis) 10/2021 - 01/2012
3	Virus Diseases (Viral Diseases) 01/2021 - 06/2007
3	Carcinogenesis 01/2018 - 01/2012
2	Herpes Simplex 06/2015 - 11/2003
1	Zika Virus Infection 01/2022
1	Herpesviridae Infections (Herpesvirus Infection) 01/2018
1	Flavivirus Infections 12/2015
1	Neoplasm Metastasis (Metastasis) 01/2012
1	Cytomegalovirus Infections (Inclusion Disease) 01/2012
1	Melanoma (Melanoma, Malignant) 02/2005

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
5	Viral ProteinsIBA 01/2022 - 11/2003
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2011
4	EBV-encoded nuclear antigen 1IBA 01/2015 - 10/2008
3	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2014
2	Capsid Proteins (Capsid Protein)IBA 01/2022 - 12/2015
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 11/2019
2	Viral DNAIBA 01/2021 - 01/2012
2	Ubiquitin-Specific ProteasesIBA 10/2018 - 11/2003
2	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 06/2012
2	ChromatinIBA 01/2013 - 11/2009
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2012 - 01/2012
2	ProteomeIBA 01/2012 - 06/2007
1	Amino Acids FDA Link 10/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2019
1	UbiquitinIBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Pharmaceutical PreparationsIBA 06/2015
1	ElementsIBA 02/2014
1	Casein Kinase II (Casein Kinase 2)IBA 01/2014
1	NucleophosminIBA 06/2012
1	RibonucleoproteinsIBA 06/2012
1	RNA (Ribonucleic Acid)IBA 06/2012
1	Epstein-Barr Virus Nuclear AntigensIBA 10/2011
1	VaccinesIBA 02/2005
1	AntigensIBA 02/2005
1	Peptides (Polypeptides)IBA 02/2005
1	Interleukin-2 (IL2)IBA 02/2005

Therapy/Procedure

2	Therapeutics 12/2015 - 06/2015